This study demonstrated that SPARC-modified ADMSC showed superior efficacy compared to either ADMSC or cyclosporine eye drops alone in promoting corneal healing, up-regulating tear secretion, and suppressing periocular inflammation in a canine model of dry eye induced with 0.25% BAC. This evidence concerns the gene SPARC and Keratoconjunctivitis sicca.